BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/6/2026 6:30:42 AM | Browse: 0 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 115289
Country Malaysia
Received
2025-10-15 07:04
Peer-Review Started
2025-10-15 07:04
First Decision by Editorial Office Director
2025-10-24 11:07
Return for Revision
2025-10-24 11:07
Revised
2025-10-30 02:43
Publication Fee Transferred
Second Decision by Editor
2026-01-06 02:37
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-01-06 08:07
Articles in Press
2026-01-06 08:07
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-02-02 03:56
Publish the Manuscript Online
2026-02-06 06:30
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Intermittent fasting enhances cancer therapy via autophagy-dependent and independent mechanisms: Evidence and implications
Manuscript Source Invited Manuscript
All Author List Mona Mohamed Ibrahim Abdalla, Payal Bhatnagar, Mohd Hazim Bin Zulkaflee, Abdul Malik Sahib Mohammed Irfan and Nabil Eid
ORCID
Author(s) ORCID Number
Mona Mohamed Ibrahim Abdalla http://orcid.org/0000-0002-4987-9517
Payal Bhatnagar http://orcid.org/0000-0002-6474-5672
Nabil Eid http://orcid.org/0000-0002-2938-2618
Funding Agency and Grant Number
Corresponding Author Nabil Eid, Associate Professor, MD, PhD, Division of Anatomy, Department of Human Biology, School of Medicine, IMU University, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur 57000, Malaysia. nabilsaleheid@imu.edu.my
Key Words Intermittent fasting; Cancer; Chemotherapy; Autophagy; Metabolic diseases; Obesity; Inflammation
Core Tip Growing evidence indicates that intermittent fasting (IF) can reduce chemotherapy-related toxicity and slow tumor growth in cancer patients through both autophagy-dependent and independent mechanisms. Therefore, IF may represent a promising strategy for cancer prevention and as an adjuvant to cancer therapy. However, there are limitations associated with IF in cancer therapy.
Publish Date 2026-02-06 06:30
Citation

Abdalla MMI, Bhatnagar P, Zulkaflee MHB, Mohammed Irfan AMS, Eid N. Intermittent fasting enhances cancer therapy via autophagy-dependent and independent mechanisms: Evidence and implications. World J Clin Oncol 2026; 17(2): 115289

URL https://www.wjgnet.com/2218-4333/full/v17/i2/115289.htm
DOI https://dx.doi.org/10.5306/wjco.v17.i2.115289
Full Article (PDF) WJCO-17-115289-with-cover.pdf
Manuscript File 115289_Auto_Edited_091626.docx
Answering Reviewers 115289-answering-reviewers.pdf
Audio Core Tip 115289-audio.mp3
Conflict-of-Interest Disclosure Form 115289-conflict-of-interest-statement.pdf
Copyright License Agreement 115289-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 115289-non-native-speakers.pdf
Peer-review Report 115289-peer-reviews.pdf
Scientific Misconduct Check 115289-scientific-misconduct-check.png
Scientific Editor Work List 115289-scientific-editor-work-list.pdf
CrossCheck Report 115289-crosscheck-report.pdf